VPC News

Dr. Miles Mannas, Senior Research Scientist at the Vancouver Prostate Centre and Assistant Professor in the UBC Department of Urologic Sciences, has received one of the Prostate Cancer Foundation’s prestigious 2026 Young Investigator Awards. Dr. Mannas’s project combines artificial intelligence with...

The M. H. Mohseni Institute of Urologic Sciences and Vancouver Prostate Centre proudly took part in this year’s Terry Fox Run at Stanley Park, with 67 registered participants and more than 45 attending in person. Together, the Institute raised more than $49,000 in support of Terry’s mission. Team...

Postdoctoral research fellows Dr. Yusuke Shiraishi and Dr. Jan Vanwelkenhuyzen of the Vancouver Prostate Centre have received 2026 Research Trainee Awards from Michael Smith Health Research BC. The awards support outstanding postdoctoral fellows and health professional researchers as they advance...

The Vancouver Prostate Centre is celebrating its co-founder and longtime leader, Dr. S. Larry Goldenberg, recipient of the 2026 UBC Medicine Bill and Marilyn Webber Lifetime Achievement Award. Driven by a belief that progress accelerates when researchers and clinicians work together, Dr. Goldenberg...

For RN Julia Krizek, a career in urology nursing has grown from an early interest in the operating room into a commitment to supporting patients both in the clinic and in the community. At the Vancouver Prostate Centre, she cares for people receiving treatment for prostate and bladder cancer...

Dr. Peter Black outlines bladder-preservation strategies in high-grade non-muscle invasive bladder cancer, covering first-line optimization through second-line options. In the BCG-naive space, the BRIDGE trial comparing gemcitabine/docetaxel to BCG has completed accrual, and the BCG plus N803...

The Vancouver Prostate Centre is proud to highlight new findings from the GUNS trial, an adaptive neoadjuvant study designed for men with high-volume, high-grade prostate cancer. Led by Dr. Martin E. Gleave, CM, MD, FRCSC, FACS, British Columbia Leadership Chair, Distinguished Professor, and...

Researchers at the Vancouver Prostate Centre led a national multicentre study demonstrating that circulating tumour DNA (ctDNA) testing can help identify patients with metastatic urothelial carcinoma who may benefit from FGFR-targeted therapies. The study, Prospective multicenter study of ctDNA...

Early-stage, low-grade bladder cancer is often described as “low risk,” yet a substantial proportion of patients experience recurrences that remain difficult to predict using conventional clinical criteria. Traditional risk assessment, such as the International Bladder Cancer Group (IBCG) guidelines...

The Vancouver Prostate Centre is proud to announce that Dr. Nada Lallous, Assistant Professor, UBC Faculty of Medicine, has been selected as a delegate for Science Meets Parliament BC 2026. Science Meets Parliament BC is a prestigious national initiative that brings together researchers and...